$50 Million Gift Set to Transform Cancer Research and Treatment in Israel

In Petah Tikva, a major breakthrough is set to strengthen Israeli medical research. The Samueli Integrative Cancer Pioneering Institute, based at the Rabin Medical Center – Beilinson Hospital, has received an exceptional $50 million donation from American philanthropists Dr. Susan Samueli and Dr. Henry Samueli. This marks their second major contribution to the research institute established within the Davidoff Cancer Center.

For Prof. Gal Markel, Director of the Davidoff Cancer Center and Chair of the Institute, the donation is “historic.”

“In just three years, our teams have reached major international milestones. The path we are paving will be adopted worldwide, bringing hope and healing,” he said.

This unprecedented funding marks a decisive step in the development of an innovative model for cancer treatment. “By combining world-class research with holistic and compassionate care, our gift aims to shape a new model of cancer treatment for the benefit of humanity,” the donors stated.

The project was launched in 2022, when Henry Samueli, co-founder of semiconductor giant Broadcom, and his wife Susan, long committed to advancing healthcare, decided to support the creation of an institute dedicated to integrative cancer medicine. Their first investment, totaling $25 million in 2023, laid the foundation for this ambitious initiative.

As early as 2024, the Institute inaugurated state-of-the-art GMP laboratories dedicated to the development and production of innovative treatments, particularly in immunotherapy. Three experimental therapies are already being tested in patients.

One of the project’s key pillars also relies on artificial intelligence. Thanks to privileged access to the extensive databases of Clalit Health Services, which cover more than half of Israel’s population, research teams are developing advanced models for early cancer detection and the prediction of clinical outcomes.

Dr. Erez Barenboim, Director of Beilinson and Hasharon Hospitals, believes this donation “positions Israel as a global powerhouse in cancer research and treatment,” while opening new perspectives for patients.

A highly promising donation that could revolutionize medical approaches in Israel and around the world.

Caroline Haïat